AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 Aug 2012 05:00 PM
RNS
Director/PDMR Shareholding
31 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
30 Aug 2012 05:00 PM
RNS
Director/PDMR Shareholding
30 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
29 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
28 Aug 2012 07:00 AM
RNS
European Commission approves Zinforo
28 Aug 2012 07:00 AM
RNS
Pascal Soriot appointed CEO
28 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
24 Aug 2012 04:00 PM
RNS
Director/PDMR Shareholding
24 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
23 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
22 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
21 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
20 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
17 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
15 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
14 Aug 2012 07:00 AM
RNS
Partners Pfizer for over-the-counter Nexium
09 Aug 2012 12:45 PM
RNS
Bristol-Myers Squibb completes purchase of Amylin
06 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
03 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
02 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
01 Aug 2012 04:00 PM
RNS
Total Voting Rights
01 Aug 2012 02:00 PM
RNS
Director/PDMR Shareholding
01 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
31 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
30 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
27 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
26 Jul 2012 07:05 AM
RNS
Transaction in Own Shares
26 Jul 2012 07:00 AM
RNS
Pipeline table: Second Quarter & Half Year(2 of 2)
26 Jul 2012 07:00 AM
RNS
Second Quarter & Half Year Results (1 of 2)
25 Jul 2012 09:00 AM
RNS
Notice of Results
25 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
24 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
23 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
20 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
19 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
18 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
17 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
16 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
13 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
12 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
11 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
10 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
09 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
06 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
05 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
04 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
03 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
02 Jul 2012 04:00 PM
RNS
Total Voting Rights
02 Jul 2012 07:00 AM
RNS
AZ expands alliance with BMS through Amlyn
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100